Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate.

Background Stent length serves as a predictor of restenosis in use of bare metal stents (BMS). This has been demonstrated in a feasibility study that used a single short BMS implant (<9 mm) in a high proportion of lesions; the study observed a low rate of restenosis.